Latest News

The 17th European Glaucoma Society (EGS) Congress—being held in Brussels, Belgium, from 30 May to 2 June 2026—brings together glaucoma specialists across plenary sessions, hands-on surgical dry labs, national society symposia and cross-specialty debates.

A retrospective study from a UK tertiary centre reports satisfactory visual and topographic outcomes in patients monitored and treated by optometrists and nurse practitioners.

The incision-free, image-guided femtosecond laser system targets the trabecular meshwork to reduce IOP without entering the eye. Prof. Gus Gazzard discusses the technology, the patient experience and the potential for earlier interventional glaucoma treatment

Swiss regulator backs tinlarebant for Stargardt as DRAGON phase 3 shows slower retinal atrophy, bringing first treatment closer to patients.

The novel dual-port cutter, designed for use with the Stellaris Elite platform, offers increased flow rate and reduced cutter vibration.

Emerging evidence repositions role of selective laser trabeculoplasty

Ultra-widefield imaging reveals early retinal risk in paediatric patients.

Professor Alió reflects on a new comprehensive volume dedicated to aging in ophthalmology

Temporal optical coherence tomography modelling may improve longitudinal disease tracking.

Understanding thyroid eye disease and its often-missed diagnosis.

A closer look at the science powering next-generation retinal treatments.

Specialists discuss diagnostic technologies, treatment strategies and research that are improving outcomes for young patients.

A neuroprotective investigational candidate for optic neuritis (ON) has received Priority Medicines (PRIME) designation from the European Medicines Agency (EMA).

Prof. Sobha Sivaprasad discusses why GA's multistage nature demands a broader therapeutic approach—and what evidence will shape clinical decision-making.

Prof. Anat Loewenstein questioned whether treat-and-extend will remain the preferred strategy as longer-acting therapies emerge.

Andrew G. Lee, MD, presents the “no” perspective on whether GLP-1 agonists cause non-arteritic anterior ischemic optic neuropathy, arguing that current evidence shows association but not proven causation.

The 17th annual Congress on Controversies in Ophthalmology takes place on 20–21 March 2026 in Kraków, Poland, bringing together an international faculty for two days of structured debate on the most pressing questions in the field.

The trial, sponsored by ONL Therapeutics, aims to enrol approximately 324 patients across sites in Europe, the United States, and Canada.

According to the manufacturer, TECNIS PureSee is the first US EDOF IOL approved by the FDA with no warning on contrast sensitivity.

The 3rd Winterthur Ophthalmology Symposium in Winterthur, Switzerland, on 12–13 March 2026 will feature plenary talks, hands-on workshops, satellite sessions, poster presentations, and a gala honoring the Otto Haab Medal.

Marta Pazos, MD, PhD, on how OCT and emerging AI can help spot preperimetric glaucoma years before vision loss while avoiding false positives from myopia and disc anatomy.

Experts share practical and research-based advancements, offering actionable strategies in diagnosis, treatment, and early detection.

Learn how OCT aids neuro-ophthalmology, where it falls short, and why AI plus neurologist–ophthalmologist teamwork prevents misdiagnosis.

Steffen Hamann, PhD, FEBO, FRCOphth, offers insight into the landscape for optic disc drusen and the impact of advances in OCT.

Healthcare staff face splashes, aerosols, chemicals, and lasers daily; ANSI-rated eye protection and better compliance prevent most workplace injuries.

An ophthalmology resident shares insights from experiences across Mexico, Europe, and the US.

The certification supports continued European market access as the Medical Device Regulation imposes stricter requirements on manufacturers.

A separate ex-US settlement enables a launch in the United Kingdom beginning January 2026, in the rest of Europe from April 2026, and in other settled markets (excluding Korea) from May 2026.

The 22nd International Scientific Symposium on Ophthalmic Imaging will take place 18–19 September 2026 in Singapore, marking an expanded scientific scope while maintaining its focus on imaging in research and clinical practice.

Proactive strategies enhance comfort, adherence and long-term glaucoma control

Marta Pazos, MD, PhD, examined the role of optical coherence tomography, artificial intelligence, and clinical evaluation in early glaucoma management.